Vaccinia Virus Strain Differences. I. Neutralization of Vaccinia Virus Strains by Homologous and Heterologous Antisera

Overview

Journal Arch Gesamte Virusforsch

Specialty Microbiology

Date 1973 Jan 1

PMID 4126981

Citations 2

Authors

R C Dunlap

L F Barker

Affiliations

Soon will be listed here.

Citing Articles

Vaccinia virus strain differences. II. Altered dermal reactivity of vaccinia virus by single passage in a new host system.

Dunlap R, Barker L Arch Gesamte Virusforsch. 1973; 42(2):117-24.

PMID: 4747046

A comparison of some immunological methods for the differentiation of strains of foot-and-mouth disease virus.

Forman A J Hyg (Lond). 1975; 74(2):215-25.

PMID: 164500 PMC: 2130370. DOI: 10.1017/s002217240002427x.

References

Yoshino K, Taniguchi S . THE APPEARANCE OF COMPLEMENT-REQUIRING NEUTRALIZING ANTIBODIES BY IMMUNIZATION AND INFECTION WITH HERPES SIMPLEX VIRUS. Virology. 1964; 22:193-201. DOI: 10.1016/0042-6822(64)90004-2. View

Neff J . The case for abolishing routine childhood smallpox vaccination in the United States. Am J Epidemiol. 1971; 93(4):245-7. DOI: 10.1093/oxfordjournals.aje.a121254. View

Majer M, Link F . Studies on the non-neutralizable fraction of vaccinia virus. Clin Exp Immunol. 1970; 7(2):283-91. PMC: 1712836. View

Daniels C, Borsos T, Rapp H, Snyderman R, Notkins A . Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A. 1970; 65(3):528-35. PMC: 282939. DOI: 10.1073/pnas.65.3.528. View

Wallis C, Melnick J . Virus aggregation as the cause of the non-neutralizable persistent fraction. J Virol. 1967; 1(3):478-88. PMC: 375261. DOI: 10.1128/JVI.1.3.478-488.1967. View

KEMPE C, FULGINITI V, Minamitani M, Shinefield H . Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CVI-78). Pediatrics. 1968; 42(6):980-5. View

Jambazian A, Holper J . Rheophoresis: a sensitive immunodiffusion method for detection of hepatitis associated antigen. Proc Soc Exp Biol Med. 1972; 140(2):560-4. DOI: 10.3181/00379727-140-36503. View

Yoshino K, Taniguchi S . STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. 3. MECHANISM OF THE ANTIBODY-POTENTIATING ACTION OF COMPLEMENT. Virology. 1965; 26:61-72. DOI: 10.1016/0042-6822(65)90026-7. View

Nishimura C, Nomura M, Kitaoka M, Takeuchi Y, Kimura M . Complement requirement of the neutralizing antibody appearing after immunization with smallpox vaccine. Jpn J Microbiol. 1968; 12(2):256-9. DOI: 10.1111/j.1348-0421.1968.tb00393.x. View

10.

McBRIDE W . Antigenic analysis of polioviruses by kinetic studies of serum neutralization. Virology. 1959; 7(1):45-58. DOI: 10.1016/0042-6822(59)90176-x. View

11.

Yoshino K, Taniguchi S . STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT. Virology. 1965; 26:44-53. DOI: 10.1016/0042-6822(65)90024-3. View

12.

Eagle H . Amino acid metabolism in mammalian cell cultures. Science. 1959; 130(3373):432-7. DOI: 10.1126/science.130.3373.432. View

13.

SCHEIDEGGER J . [A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol. 1955; 7(2):103-10. View

14.

BENENSON A . Possible alternatives to routine smallpox vaccination in the United States. Am J Epidemiol. 1971; 93(4):248-52. DOI: 10.1093/oxfordjournals.aje.a121255. View

15.

Ashe W, Notkins A . Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin. Proc Natl Acad Sci U S A. 1966; 56(2):447-51. PMC: 224392. DOI: 10.1073/pnas.56.2.447. View

16.

. [Enhancement of neutralization of vaccinia virus by antiglobulin]. Arch Gesamte Virusforsch. 1970; 31(1):28-32. View

17.

Lane J, MILLAR J . Risks of smallpox vaccination complications in the United States. Am J Epidemiol. 1971; 93(4):238-40. DOI: 10.1093/oxfordjournals.aje.a121252. View

18.

Dunlap R . Virus particle content of smallpox vaccines. Appl Microbiol. 1970; 19(4):689-93. PMC: 376761. DOI: 10.1128/am.19.4.689-693.1970. View

19.

FOEGE W, Foster S, Goldstein J . Current status of global smallpox eradication. Am J Epidemiol. 1971; 93(4):223-33. DOI: 10.1093/oxfordjournals.aje.a121250. View

20.

OUCHTERLONY O . Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958; 5:1-78. View